Forty51 Ventures logo

Forty51 Ventures

Europe, Basel-Stadt, Switzerland, Basel

Description

Forty51 Ventures is the Biotech Venture Capital.

Investor Profile

Forty51 Ventures has backed more than 5 startups, with 1 new investments in the last 12 months alone. The firm has led 3 rounds, about 60% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series A rounds (top funding stages).
  • Majority of deals are located in Switzerland, United States.
  • Strong thematic focus on Therapeutics, Biotechnology, Pharmaceutical.

Stage Focus

  • Seed (80%)
  • Series A (20%)

Country Focus

  • Switzerland (80%)
  • United States (20%)

Industry Focus

  • Therapeutics
  • Biotechnology
  • Pharmaceutical
  • Health Care
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Forty51 Ventures frequently co-invest with?

Norwest Venture Partners
North America, California, United States, Palo Alto
Co-Investments: 1
HTGF | High-Tech Gruenderfonds
Europe, Nordrhein-Westfalen, Germany, Bonn
Co-Investments: 2
Forbion Capital Partners
Europe, Noord-Holland, The Netherlands, Naarden
Co-Investments: 1
Broadview Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 1
EQT Life Sciences
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 1
Pivotal bioVenture Partners
North America, California, United States, San Francisco
Co-Investments: 1
Supermoon Capital
North America, California, United States, San Francisco
Co-Investments: 2

What are some of recent deals done by Forty51 Ventures?

Allegria Therapeutics

Basel, Basel-Stadt, Switzerland

Allegria Therapeutics is a biotech firm that engages in the research and treatment of allergy and mast cell-mediated inflammatory diseases.

BiotechnologyHealth DiagnosticsLife ScienceTherapeutics
SeedDec 11, 2025
Amount Raised: $5,100,000
Mosanna Therapeutics

Redwood City, California, United States

Mosanna Therapeutics develops a nasal spray for treating obstructive sleep apnea.

BiotechnologyPharmaceuticalTherapeutics
Series AJun 9, 2025
Amount Raised: $80,000,000
Allegria Therapeutics

Basel, Basel-Stadt, Switzerland

Allegria Therapeutics operates as a biotech company.

SeedMay 6, 2024
Amount Raised: $3,500,000
Mysthera Therapeutics

Basel, Basel-Stadt, Switzerland

Mysthera Therapeutics is a pharmaceutical company.

Health CareMedicalTherapeutics
SeedAug 21, 2023
Amount Raised: $3,500,000
Mosanna Therapeutics

Basel, Basel-Stadt, Switzerland

Mosanna Therapeutics is a Biotech company based in Basel with a commitment to improving patient outcomes and quality of life.

BiotechnologyTherapeutics
SeedApr 11, 2023
Mosanna Therapeutics

Basel, Basel-Stadt, Switzerland

Mosanna Therapeutics is a Biotech company based in Basel with a commitment to improving patient outcomes and quality of life.

BiotechnologyTherapeutics
SeedJul 13, 2022

Find More Investors Like Forty51 Ventures

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Forty51 Ventures | Pipeseed